RM EN DE MAMA EN PACIENTES DE RIESGO.
REVISIÓN DEL TEMA
Palabras clave:
RM DE MAMA, POSTER, SERAMResumen
Objetivos
• Definir riesgo y niveles de riesgo en el cáncer de mama
• Establecer guías para reducir los falsos positivos en RM
• Lograr una tabla de indicación de RM de mama en pacientes con riesgo elevado de cáncer de mama
Material y métodos
Revisión de la literatura reciente sobre la categorización del riesgo de padecer cáncer de mama para definir los grupos de riesgo para esta patología.
Identificación de los avances técnicos y de interpretación de las imágenes de RM de mama que puedan ayudar a mejorar la especificidad de la técnica, especialmente evitando falsos positivos.
Revisión de las guías aprobadas en el seguimiento con imagen de las pacientes de riesgo para carcinoma de mama y de las publicaciones más recientes al respecto, para tratar de sintetizarlas en una tabla que recoja las indicaciones de la RM de mama en este subgrupo de pacientes.
Descargas
Citas
Mori N, Ota H, Mugikura S, et al. Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index. Radiology. 2015 Jan;274(1):66-73.
Kuhl CK, Klaschik S, Mielcarek P, et al. Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI. J Magn Reson Imaging. 1999 Feb;9(2):187-96.
Danishad KK, Sharma U, Sah RG, et al. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). NMR Biomed 2010 Apr;23(3):233-41. doi: 10.1002/nbm.1436.
Etzioni R, Xia J, Hubbard R, Weiss NS, Gulati R. A reality check for overdiagnosis estimates associated with breast cancer screening. J Natl Cancer Inst. 2014 Oct 31;106(12).
Khul CK. The changing world of breast cancer. A radiologist´s perspective. Invest Radiol. 2015; 50(9): 615-28.
Mann RM, et al. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol. 2008; 18(7): 1307
Francesco Sardanelli. Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group European Journal of Cancer vol. 46, 1296 - 1316, 2010
Beran L, Liang W, Nims T, et al. Correlation of targeted ultrasound with magnetic resonance imaging abnormalities of the breast. Am J Surg 2005;190(4): 592–4.
Kuhl CK. MR imaging for surveillance of women at high familial risk for breast cancer. Magn Reson Imaging Clin N Am. 2006 Aug;14(3):391-402.
Khul CK, Schrading S, Bieling HB et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007; 370: 485-92.
Sung JS, LeeCH, Morris EA, et al. Screening breast MR imaging in women with a history of chest irradiation. Radiology. 2011; 259: 65-71.
Sung JS, Lee CH, Morris EA., et al Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology. 2011; 261: 414-20.
Berg WA, Zhang Z, Lehrer D, et al. ACRIN 6666 Investigators. Detection of breast cancer wit addition of annual screening ultrasound or a single screening MRI to mamography in women with elevated breast cancer risk. JAMA. 2012; 307: 1394-1404.
Lee JM, McMahon PM, Kong CY, et al. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers. Radiology 2010; 254: 793-800
Plevritis SK, Kurian AW; Sigal BM et al. Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging. JAMA 2006; 295 (20): 2374-2384
Taneja C, Edelsverg J, Weycker D, et al. Cost Effectiveness of Breast Cancer Screening With Contrast-Enhanced MRI in High-Risk Women. J Am Coll Radiol 2009; 6(3): 171-179
Kuhl C, Schrading S, Strobel K, et al. Abbreviated Breast Magnetic Resonance Imaging (MRI): First Postcontrast Subtracted Images and Maximum-Intensity Projection—A Novel Approach to Breast Cancer Screening With MRI. J Clin Oncol 2014; 32: 2304
American College of Radiology ACR Appropriateness Criteria. http://www.acr.org/-/medias/ACR/Documents/AppCriteria/Diagnostic/BreastCancerScreening.pdf
NICE guidelines. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. NICE guidelines (CG164). June 2013.
de Gonzalez A, Berg CD, Visvanathan K, et al. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst 2009; 101(3): 205-(9).
Tilanus-Linthorst MM, Obdeijn IM, Hop WCJ, et al. BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials Clin Cancer Res 2007; 13: 7357-62.
Wamer E, Messersmith H, Causer P, et al. Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer. Ann Intern Med 2008; 148(9): 671.
Schwartz T, Cyr A, Margenthaler J. Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res. 2015; 193(2): 519-22.
Gweon HM, Cho N, Han W, et al. Breast MR imaging screening in women with a history of breast conservation therapy. Radiology. 2014; 272(2): 366-73.
Schatch DV, Yamaguchi K, Lai J, et al. Importance of a personal history of breast cancer as a risk factor for the development of subsequent breast cancer: results from screening breast MRI. AJR. 2014. 202(2): 289-92.
Lehman CD, Lee JM, DeMartini WD, et al. Screening MRI in women with a personal history of breast cancer. J Natl Cancer Inst. 2016; 108(3): 1-8.
Assi V, Warwick J, Cuzick J et al. Clinical and epidemiological issues in mammographic density. Nat Rev Clin Oncol. 2012; 9: 33-40.
